Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Jean-René Sautier

Jean-François Dehecq

Sanofi

Alpha Leonis Partners offers custom strategic investment advisory solutions for client assets, investing across private and capital markets primarily in Europe and North America.

Alpha Leonis Partners

LégiaPark is an economic activity center dedicated to hosting companies active in life sciences. It provides a suitable environment for research, production, or commercialization activities.

LégiaPark

Acerta Pharma, an affiliate of AstraZeneca, develops and delivers targeted novel transformational medicines for patients with hematological malignancies.  Acerta Pharma uses innovative approaches to discover, develop, and deliver targeted medicines, focusing on innovative clinical strategies and resistance biology.

Acerta Pharma

Sanofi is a global healthcare and pharmaceutical company that focuses on advancing healthcare, developing innovative medicines and vaccines, and improving people's health and quality of life. The company is self-described as innovative in its approach to research and development.

Medley

Sanofi Pasteur MSD

Sanofi Polska

Sanofi Belgium

Shantha Biotechnics Limited,Part of Sanofi Aventis Group

Chattem, Inc.

Foundation S

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. 

Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.

Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

BioNTech

Warp Drive Bio

Provention Bio

Melinta Therapeutics

Regulus Therapeutics

Gyroscope Therapeutics

Icosavax

Exscientia

Fulcrum Therapeutics

MyoKardia

Nereus Pharmaceuticals

Innovent Biologics

Eden Biologics

Evotec

Blackstone Life Sciences

Merci Paris 2024 ✨
Merci Team Sanofi 💜
Merci Sanofi Volunteers 🫶

What an unforgettable experience these Games have been! We showed the world how science and sport are so closely connected. It’s all about the determination and resilience that bring us together. 💜

#WeNeverSettle #IgnitingPotential #TeamSanofi #Paris2024 #Paralympics
Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024

👉 We’re taking you through the streets of Paris during the #Paris2024 Paralympic Games, zooming in on the #MeningitisFlag campaign displayed at the Franklin D. Roosevelt metro station. 

With the Games lighting up Paris, this is an experience in its own right: one dedicated to the fight against meningitis, featuring para-athletes Ellie Challis, Theo Curin, and Davide Morana proudly flying the #MeningitisFlag. 💛💜💙

Participate from where you stand and click here to raise their score: http://spkl.io/6041fBtbD 

#DefeatMeningitis #ParalympicGames
Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024 
Meningitis Research Foundation

Team Sanofi is back, taking over Paris once again!  ✨ 
 
Discover the inspiring stories of our #TeamSanofi athletes & Sanofi scientists! See how their friends, loved ones, and mentors supported and encouraged them to never settle in their pursuit of dreams. 

Missed it in Paris? Catch up and learn more here: https://lnkd.in/dTWPBpMb

#IgnitingPotential #WeNeverSettle #Paris2024 #Paralympics
Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024

Our #volunteers are bringing incredible energy to the #Paralympics! Thanks for bringing out the magic of the Games and making them unforgettable! We couldn’t be prouder of our amazing Sanofians 💜✨
#Paris2024 #IgnitingPotential #WeNeverSettle

New positive Phase 3 results on our BTKi for people living with non-relapsing secondary progressive #MultipleSclerosis. These results have the potential to provide a new treatment for those who have no options. Update on relapsing MS results. 

To learn more, read our press release: https://lnkd.in/etvySDp5

Explore the story of the #MeningitisFlag campaign in Paris, from idea 💡to execution 🖼️

🏅 During the #Paris2024 Paralympic Games, Ellie Challis, Theo Curin and Davide Morana picked their side, the one in the fight against #meningitis.  

📣 And now it’s time to pick your side. 

Let’s fly the Meningitis Flag together. Show your support by commenting: 💛💜💙 

Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024 

Meningitis Research Foundation 

#DefeatMeningitis

Ready, set, GO! The #Paris2024 #Paralympic Games are here! 

We’re off to a strong start with our Team Sanofi Athlete Nantenin KEITA lighting up the Opening Ceremony as a flag bearer and torchbearer, following her iconic relay with the Olympic Flame Paris 2024! 🌟 

Our volunteers are ready to bring the Games to life, and all Sanofians are geared up to cheer on our #TeamSanofi athletes.  

You’ve got this, Lauren Rowles, Ezra Frech, Ellie Challis, and Nantenin Keita! ✨ 

Last but not least, let’s make a difference by flying the #MeningitisFlag high during these Games!  💛💜💙 

#IgnitingPotential #WeNeverSettle #Paralympics #OpeningCeremony 
Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024

The past 24 hours have been nothing short of ✨MAGICAL✨—and this is just the beginning! Here are the highlights👇 
 
🐎 Our iconic Metal Horse from the Olympic Games Paris 2024 Opening Ceremony is now proudly showcased at the mayor’s office in Paris. 
 
✨ Our extraordinary Sanofi volunteers have traveled across the globe, ringing in plenty of energy and motivation, for a kick-off at the UNESCO House in Paris!   
 
🔥 The #Paris2024 Paralympic Flame stopped at La Maison Sanofi! Our CEO Paul Hudson and our Executive VP Corporate Affairs Audrey Duval proudly carried the Flame to our HQ where ecstatic Sanofians cheered them on! 
 
#Paralympics #Paris2024 
Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024

The Torch Relay is back, and this time, for the Paris 2024 Paralympic Games! To keep the excitement going, we’re showcasing more stories from our very own Sanofi Torchbearers 🔥💜 

Meet Rafik Amrane, former Olympic Rower and Paris 2024 Olympic Torchbearer. Like Olympic and Paralympic athletes, we’re always pushing the limits of what’s possible. For us, that means chasing the miracles of science! 

We’re proud that 42 Sanofi employees are carrying the Paris 2024 Paralympic Flame across 24 cities. This journey will end on a high note for us, with the Flame stopping at our Paris HQ!  

#IgnitingPotential #Paralympics #Paris2024 

Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024

Each Sanofian plays an important role in chasing the miracles of science to improve people’s lives ✨ 

Samantha, a Site Quality Operations Manager in the US, who was also a volunteer for the #Paris2024 Olympic Games, appreciates how her colleagues bring their backgrounds and experiences together to reach a common goal. 

Her role has given her more courage and confidence to never settle, even outside of work.

Learn more about how we’re working together to build a healthier, more resilient world: http://spkl.io/6049f6ZTN 

#WeNeverSettle

Metric
Company Name	Sanofi	Alpha Leonis Partners	LégiaPark	Acerta Pharma
Symbol	SAN
MSH ID	COM:SANOFI	COM:ALPHALEONISPARTNERS	BE:LEGIAPARK	COM:ACERTA-PHARMA
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Financial Services & Finance	Commercial & Professional Services	Healthcare & Health Services
Industry	Drug Manufacturers - General	Investment Management	Life Sciences	Pharmaceutical
Country	FR	CH	BE	NL
Stage
Employee Count	86.09K
Website	sanofi.com	alphaleonispartners.com	legiapark.be	acerta-pharma.com
LinkedIn	sanofi		l%C3%A9giapark
Founders

Metric
Market Cap	125.22B
Enterprise Value
Monthly Web Traffic	1.77M	90
Web Traffic Growth	1.26	0.80
Valuation
Raised Capital	329.02M

Metric
Revenue	45.49B
Revenue (LTM)
Revenue (NTM)
Gross Profit	27.99B
EBITDA	13.69B
Operating Income	9.70B
Net Income	5.70B
EPS	4.55
Diluted EPS	4.54
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.68
Operating Profit Margin	0.26
EBITDA Margin	0.30
Net Profit Margin	0.14
Return on Equity	0.11
Return on Assets	0.06
Return on Capital Employed	0.15

COM:SANOFI

Sanofi

Last Close

93.17

25/11 09:25

Market Cap

118.54B

Beta: -

Volume Today

80.94K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	12.01
P/B Ratio	1.51
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	2.28
EV Multiple	7.47

Metric
Days Sales Outstanding	2.82
Days Payables Outstanding	505.63
Days Inventory Outstanding	205.19
Operating Cycle	262.40
Cash Conversion Cycle	116.95
Asset Turnover	0.52

Metric
Operating Cash Flow	10.83B
Free Cash Flow	7.40B
Cash Flow to Debt	0.62
Operating Cash Flow/Sales	0.18
Free Cash Flow Yield

Metric
Cash & Equivalents	9.20B
Accounts Receivable	-419.32M
Inventory	10.21B
Goodwill	52.18B
Debt to Capitalization	0.23
Debt to Assets	0.17
Current Ratio	1.22
Quick Ratio	0.83

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.15
SG&A to Revenue